← Back to Search

Smartphone App for Cancer Medication Adherence

N/A
Recruiting
Led By Melissa Accordino, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will study whether a Medisafe App can help improve medication adherence in cancer patients receiving either oral anticancer agents or oral medications for chronic disease management.

Who is the study for?
This trial is for cancer patients of any stage or type who are taking oral anticancer drugs or other medications for chronic conditions alongside their cancer treatments. Participants must be able to fill out questionnaires in English or Spanish, have a smartphone or tablet compatible with the Medisafe App, and can consent to join.Check my eligibility
What is being tested?
The study tests if a smartphone app (Medisafe App) helps cancer patients take their medication on time. It's not random; everyone gets the app and researchers will see if it improves how well they follow their medication schedule over 12 weeks using surveys and interviews.See study design
What are the potential side effects?
Since this trial involves using an app rather than a drug, there aren't typical medical side effects. However, participants may experience issues related to technology use such as frustration with the app interface or privacy concerns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of subjects enrolled that complete the 12-week intervention and assessments
Secondary outcome measures
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Score before and after the intervention
Change in Treatment Satisfaction Questionnaire for Medication (TSQM) Domain Score before and after the intervention
Change in mean score on the Voils Extent of Adherence Scale for global medication use between baseline and 12 weeks
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Smartphone App InterventionExperimental Treatment1 Intervention
Cancer patients taking at least one oral anti-cancer drug or oral medication to manage a chronic condition in conjunction with any cancer treatment will receive messages through the Medisafe App.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,438 Previous Clinical Trials
2,448,695 Total Patients Enrolled
Melissa Accordino, MDPrincipal InvestigatorAssistant Professor of Medicine
3 Previous Clinical Trials
222 Total Patients Enrolled

Media Library

Smartphone App Clinical Trial Eligibility Overview. Trial Name: NCT05225090 — N/A
Cancer Research Study Groups: Smartphone App Intervention
Cancer Clinical Trial 2023: Smartphone App Highlights & Side Effects. Trial Name: NCT05225090 — N/A
Smartphone App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05225090 — N/A
~19 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top